ANAPTYSBIO, INC. Earnings Per Share (Diluted)
ANAPTYSBIO, INC. (ANAB) reported Earnings Per Share (Diluted) of $3.50 per share for the 6-month period ending 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-09-21
- ANAPTYSBIO, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $3.97.
- ANAPTYSBIO, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.84.
- ANAPTYSBIO, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $1.47.
- ANAPTYSBIO, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.52.
- ANAPTYSBIO, INC. earnings per share, diluted for fiscal 2025 was -$0.44.
- ANAPTYSBIO, INC. earnings per share, diluted for fiscal 2024 was -$4.92.
- ANAPTYSBIO, INC. earnings per share, diluted for fiscal 2023 was -$6.08.
- ANAPTYSBIO, INC. earnings per share, diluted for fiscal 2022 was -$4.57.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.97 derived: net income ÷ weighted average shares · filed 2026-09-21 | $3.50 10-KT · filed 2026-09-21 | $4.99 derived: net income ÷ weighted average shares · filed 2026-09-21 | $5.69 derived: net income ÷ weighted average shares · filed 2026-09-21 | ||
| 2026-03-31 | -$1.84 10-Q · filed 2026-05-12 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-09-21 | $0.39 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-09-21 | ||
| 2025-12-31 | $1.47 derived: net income ÷ weighted average shares · filed 2026-09-21 | $2.06 derived: net income ÷ weighted average shares · filed 2026-09-21 | $0.86 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$0.44 10-KT · filed 2026-09-21 | -$0.46 10-K · filed 2026-03-03 | |
| 2025-09-30 | $0.52 10-Q · filed 2025-11-04 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$2.16 10-Q · filed 2025-11-04 | -$2.74 derived: net income ÷ weighted average shares · filed 2026-09-21 | ||
| 2025-06-30 | -$1.34 10-Q · filed 2025-08-06 | -$2.54 10-KT · filed 2026-09-21 | -$2.62 10-Q · filed 2025-08-06 | -$3.16 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$4.30 derived: net income ÷ weighted average shares · filed 2026-09-21 | |
| 2025-03-31 | -$1.28 10-Q · filed 2026-05-12 | -$1.86 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$2.98 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$4.61 derived: net income ÷ weighted average shares · filed 2026-09-21 | ||
| 2024-12-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$3.33 derived: net income ÷ weighted average shares · filed 2026-09-21 | -$4.92 10-KT · filed 2026-09-21 | -$5.12 10-K · filed 2025-02-27 | |
| 2024-09-30 | -$1.14 10-Q · filed 2025-11-04 | -$2.83 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$4.46 10-Q · filed 2025-11-04 | -$6.04 derived: net income ÷ weighted average shares · filed 2026-06-29 | ||
| 2024-06-30 | -$1.71 10-Q · filed 2025-08-06 | -$3.35 10-Q · filed 2025-08-06 | -$4.93 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$6.34 derived: net income ÷ weighted average shares · filed 2026-06-29 | ||
| 2024-03-31 | -$1.64 10-Q · filed 2025-05-05 | -$3.23 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$4.63 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$6.13 derived: net income ÷ weighted average shares · filed 2026-06-29 | ||
| 2023-12-31 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$4.49 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$6.08 10-K · filed 2026-03-03 | ||
| 2023-09-30 | -$1.41 10-Q · filed 2024-11-05 | -$2.90 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$4.49 10-Q · filed 2024-11-05 | -$5.40 derived: net income ÷ weighted average shares · filed 2025-02-27 | ||
| 2023-06-30 | -$1.50 10-Q · filed 2024-08-05 | -$3.08 10-Q · filed 2024-08-05 | -$3.99 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$5.17 derived: net income ÷ weighted average shares · filed 2025-02-27 | ||
| 2023-03-31 | -$1.58 10-Q · filed 2024-05-09 | -$2.51 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$3.69 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$4.84 derived: net income ÷ weighted average shares · filed 2025-02-27 | ||
| 2022-12-31 | -$0.93 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.11 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$3.27 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$4.57 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$1.18 10-Q · filed 2023-11-02 | -$2.34 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$3.64 10-Q · filed 2023-11-02 | -$4.83 derived: net income ÷ weighted average shares · filed 2024-03-11 | ||
| 2022-06-30 | -$1.15 10-Q · filed 2023-08-07 | -$2.46 10-Q · filed 2023-08-07 | -$3.64 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$3.90 derived: net income ÷ weighted average shares · filed 2024-03-11 | ||
| 2022-03-31 | -$1.31 10-Q · filed 2023-05-11 | -$2.49 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.74 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.76 derived: net income ÷ weighted average shares · filed 2024-03-11 | ||
| 2021-12-31 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.43 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.11 10-K · filed 2024-03-11 | ||
| 2021-09-30 | -$0.24 10-Q · filed 2022-11-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.92 10-Q · filed 2022-11-08 | $0.31 derived: net income ÷ weighted average shares · filed 2023-03-01 | ||
| 2021-06-30 | -$0.02 10-Q · filed 2022-08-08 | -$0.68 10-Q · filed 2022-08-08 | $0.55 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-01 | ||
| 2021-03-31 | -$0.66 10-Q · filed 2022-05-04 | $0.57 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-03-01 | ||
| 2020-12-31 | $1.23 derived: net income ÷ weighted average shares · filed 2023-03-01 | $0.36 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-03-01 | -$0.73 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$0.87 10-Q · filed 2021-11-04 | -$1.66 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$1.96 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$0.79 10-Q · filed 2021-08-09 | -$1.09 10-Q · filed 2021-08-09 | ||||
| 2019-12-31 | -$0.75 10-K · filed 2020-03-02 | -$3.60 10-K · filed 2022-03-07 | ||||
| 2019-09-30 | -$1.15 10-K · filed 2020-03-02 | |||||
| 2019-06-30 | -$0.89 10-K · filed 2020-03-02 | |||||
| 2019-03-31 | -$0.82 10-K · filed 2020-03-02 | |||||
| 2018-12-31 | -$0.64 10-K · filed 2020-03-02 | -$2.50 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$0.66 10-K · filed 2020-03-02 | |||||
| 2018-06-30 | -$0.57 10-K · filed 2020-03-02 | |||||
| 2018-03-31 | -$0.63 10-K · filed 2020-03-02 | |||||
| 2017-12-31 | -$0.30 10-K · filed 2019-02-28 | -$1.52 10-K · filed 2019-02-28 | ||||
| 2017-09-30 | -$0.45 10-K · filed 2019-02-28 | -$0.58 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$1.24 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | -$0.13 10-K · filed 2019-02-28 | -$0.79 10-Q · filed 2017-08-10 | ||||
| 2017-03-31 | -$0.75 10-K · filed 2019-02-28 | |||||
| 2016-12-31 | -$1.73 10-K · filed 2018-03-05 | -$1.62 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | -$0.42 10-K · filed 2018-03-05 | $0.39 derived: net income ÷ weighted average shares · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $0.05 10-K · filed 2018-03-05 | $0.00 10-Q · filed 2017-08-10 | ||||
| 2016-03-31 | -$0.34 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |